NCT04127149 2025-12-19
EPEMedG
Hospices Civils de Lyon
Phase NA Completed
Clinical Trials
15 trialsNCT01766739 2024-10-26
Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01999985 2020-11-27
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT03543462 2020-05-22
DRAGON
Catholic University of the Sacred Heart
Phase 4 Completed
NCT00299962 2020-03-18
Gene Therapy for Pleural Malignancies
University of Pennsylvania
Phase 1 Completed
NCT01722149 2019-08-07
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
University of Zurich
Phase EARLY_PHASE1 Completed
NCT02500277 2018-08-31
COFFEE
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase NA Completed
NCT00942825 2017-05-24
CBP08-02
CanBas Co. Ltd.
Phase 2 Completed
NCT00753714 2016-10-17
ZELIG
Sanofi
Phase 2 Completed
NCT00896285 2015-07-20
TIME-1
University of California, Davis
Phase NA Completed
NCT00799240 2014-11-07
IMPACT
University of Kansas Medical Center
Phase 2 Completed
NCT01776372 2014-05-13
Comparison of Pleural Drainage Systems on Reducing Pleural Effusion Formation Following Lung Resection
McMaster University
Phase NA Completed
NCT00005906 2010-04-30
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00789087 2008-11-11
Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion
University of Sao Paulo
Phase 4 Completed
NCT00720954 2008-07-23
Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy
Eskisehir Osmangazi University
Phase NA Completed